Research & Development
With increasing research into the microbiome, it is becoming clearer and clearer that our intestinal bacteria play a central role in our health and development – and therefore also the treatment – of diseases. Through its research, Institut AllergoSan is playing a decisive role in shaping 21st-century medicine. Research is conducted on bacteria that naturally occur in the human body.
Numerous clinical studies clearly prove the benefits of taking probiotic bacteria in very different clinical pictures, from antibiotic-associated diarrhoea to depression to recurrent bacterial vaginosis.
Institut AllergoSan has been inextricably linked with probiotic research and therapy for over 30 years. Anita Frauwallner, founder and director of Institut AllergoSan explains: “Research and high-quality studies are the cornerstone of our probiotics. We specifically select bacterial strains that occur in a healthy human body and therefore have the best possible conditions to settle and multiply in our intestines. And we also show this in clinical trials conducted by renowned clinics.” Doctors and pharmacists trust these probiotics because there is corresponding evidence of efficacy, which is published in high-ranking scientific journals.
Quality Criteria
WHO, WGO, FDA and OePROM Criteria
International Studies
More about past studies and ongoing research projects
What product is best suited to you?
Consult our OMNi-BiOTiC® experts
Are you looking for the right multispecies probiotic for your problems? Or looking for specific vitamins and minerals?
